insights_auto
Why is MBIO down 7.37%?
Dive Deeperchevron_right
MBIO:NASDAQ
Mustang Bio Inc
$0.42
arrow_downward
-7.37%(-0.033) 1D
$0.40
arrow_downward
-4.03% (-0.017)bedtimeAfter hours
Closed: Oct 8, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MBIO...
Open
$0.45
High
$0.45
Low
$0.41
Mkt. cap
3.16M
Avg. vol.
26.25K
Volume
101.12K
52-wk high
$1.84
52-wk low
$0.41
EPS
-$0.46
Beta
2.09
Shares outstanding
6.73M
No. of employees
4
Open
$0.45
High
$0.45
Low
$0.41
Mkt. cap
3.16M
Avg. vol.
26.25K
Volume
101.12K
52-wk high
$1.84
52-wk low
$0.41
EPS
-$0.46
Beta
2.09
Shares outstanding
6.73M
No. of employees
4
News stories
From web sources and news partners
Profile
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
About Mustang Bio Inc
CEOManuel Litchman
Employees4
Founded2015
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitemustangbio.com